Qualigen Therapeutics Inc.

QLGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.21

$0.00 (0.00%)

Nov 2, 2026, 3:52 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.43M

Enterprise Value $4.89M

Beta 0.28

Average Volume 2.65M

Shares Outstanding (Diluted) 20.29M

Shares Change YoY 1104.73%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US74754R3012

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y -34.1%

Price Change 3Y -93.1%

Price Change 5Y -99.5%

1M CAGR (ann.) -40.9%

1Y CAGR (ann.) -20.0%

5Y CAGR (ann.) -72.2%

All-Time CAGR -69.3%

Valuation

PE Ratio -0.51

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.96

P/FCF Ratio -0.45

P/Adj. FCF Ratio -0.45

P/OCF Ratio -5.35

EV/Sales N/A

EV/EBIT -1.56

EV/EBITDA -0.30

EV/FCF -0.40

Earnings Yield -195.9%

FCF Yield -224.7%

Adj. FCF Yield -224.7%

Financial Health

Net Cash $537.77K

Total Debt $39.56K

Cash & Short-Term Investments $577.33K

Total Assets $7.4M

Current Ratio 3.68

Quick Ratio 3.68

Debt / Equity Ratio 0.01

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -308.51

Interest Coverage -19.89

Altman Z-Score -27.18

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -344.0%

Return on Equity -108.3%

Return on Invested Capital -281.2%

Return on Capital Employed -283.1%

Return on Tangible Assets -379.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -75.3%

Revenue CAGR 10Y -0.9%

EPS CAGR 3Y -59.7%

EPS CAGR 5Y -2.2%

EPS CAGR 10Y 18.2%

FCF CAGR 3Y -31.8%

FCF CAGR 5Y 7.7%

FCF CAGR 10Y 3.2%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 18, 2026

EPS Estimate (next Q) -$70.00

EPS Growth Est (next Q) 6900.0%

Revenue Est (next Q) $1.2M

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-12.2M

Free Cash Flow $-12.2M

Adj. Free Cash Flow $-12.2M

FCF Per Share -$0.60

OCF Per Share -$0.60

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-16.09M

EBITDA $-16.24M

Net Income $-25.46M

EPS (Diluted) -$6.29

Revenue / Employee N/A

Profit / Employee $-6.37M

Employees 4